COVID-19 and flu antivirals on SilverScript Choice (S5601-030)
Paxlovid, Lagevrio, oseltamivir and Xofluza, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Indiana + 1 more
- Premium
- $29.70/month
- Deductible
- $615.00
2 of 4 COVID and flu antivirals are covered on this plan. None require prior authorization.
2 aren't on the formulary (Lagevrio and Xofluza).
- $10.00Tier 2
- $10.00Tier 2
Not on the formulary
Lagevrio, Xofluza
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.